Cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections

被引:3
|
作者
Wang, Rui [1 ]
Hacker, Michele R. [1 ,2 ,3 ]
Lefevre, Roger [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Obstet, Gynecology, 330 Brookline Ave, Kirstein 3, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Obstet, Gynecology, Reprod Biol, Boston, MA 02115 USA
[3] Chan Sch Publ Hlth, Dept Epidmiol, Harvard T, Boston, MA 02115 USA
关键词
Costs and cost analysis; Cost-benefit analysis; Antibiotic prophylaxis; Urinary tract infections; Catheter-related infections;
D O I
10.1007/s00192-019-04034-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose We evaluate the cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections. Materials and methods A decision tree model was used to assess the cost-effectiveness of prophylactic antibiotics in preventing catheter-associated urinary tract infections for patients with a short-term indwelling urinary catheter. The model accounted for incidence of urinary tract infections with and without the use of prophylactic antibiotics, incidence of antibiotic-resistant urinary tract infections, as well as costs associated with diagnosis and treatment of urinary tract infections and antibiotic-resistant urinary tract infections. Costs were calculated from the health care system's perspective. We conducted one-way sensitivity analyses. Results The base case analysis showed that the use of prophylactic antibiotics is cost-saving in preventing catheter-associated urinary tract infections. The use of prophylactic antibiotics resulted in lower costs and higher quality-adjusted life-years compared with no prophylactic antibiotics. Sensitivity analyses showed that the optimal strategy changes to no prophylactic antibiotics when the incidence of urinary tract infections after prophylactic antibiotics exceeds 22% or the incidence of developing urinary tract infections without prophylactic antibiotics is less than 12%. Varying the costs of prophylactic antibiotics, urinary tract infection treatment, or antibiotic-resistant urinary tract infection treatment within a reasonable range did not change the optimal strategy. Conclusions Prophylactic antibiotic use to prevent catheter-associated urinary tract infections is cost-effective under most conditions. These results were sensitive to the likelihood of developing catheter-associated urinary tract infections with and without prophylactic antibiotics. Our results are limited to the cost-effectiveness perspective on this clinical practice.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 50 条
  • [41] Preventing Catheter-Associated Urinary Tract Infections Reply
    Saint, Sanjay
    Greene, M. Todd
    Fakih, Mohamad G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13): : 1298 - +
  • [42] Catheter-associated urinary tract infections: Pathogenesis and prevention
    Skrepetis, K. M.
    Makris, A.
    ARCHIVES OF HELLENIC MEDICINE, 2009, 26 (06): : 741 - 750
  • [43] Strategies for Preventing Catheter-associated Urinary Tract Infections
    Assadi, Farahnak
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2018, 9
  • [44] Reducing catheter-associated urinary tract infections in the ICU
    Sampathkumar, Priya
    CURRENT OPINION IN CRITICAL CARE, 2017, 23 (05) : 372 - 377
  • [45] Effectiveness of an External Urinary Device for Female Anatomy and Trends in Catheter-Associated Urinary Tract Infections
    Beeson, Terrie
    Pittman, Joyce
    Davis, Carmen R.
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2023, 50 (02) : 137 - 141
  • [46] Non-antibiotic prevention strategies against catheter-associated urinary tract infections
    Laan, Bart J.
    Geerlings, Suzanne E.
    LANCET INFECTIOUS DISEASES, 2019, 19 (06): : 562 - 564
  • [47] Review of Catheter-Associated Urinary Tract Infections and In Vitro Urinary Tract Models
    Cortese, Yvonne J.
    Wagner, Victoria E.
    Tierney, Morgan
    Devine, Declan
    Fogarty, Andrew
    JOURNAL OF HEALTHCARE ENGINEERING, 2018, 2018
  • [48] The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review
    Hollenbeak, Christopher S.
    Schilling, Amber L.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (07) : 751 - 757
  • [49] CIPROFLOXACIN TO PREVENT CATHETER-ASSOCIATED URINARY-TRACT INFECTION
    MOUNTOKALAKIS, TD
    BETROSIAN, AP
    LANCET, 1992, 339 (8806): : 1422 - 1423
  • [50] Strategies to Prevent Catheter-Associated Urinary Tract Infection Reply
    Lo, Evelyn
    Nicolle, Lindsay E.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (04): : 405 - 406